NAM is the official provider of online scientific reporting for the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), taking place in Vancouver, Canada, 19th-22nd July 2015.

Conference highlights

HIV treatment access

Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide.

Conference bulletins

Catch up with conference news in our email summary bulletins. Available in English, French, Italian, Portuguese, Russian and Spanish.

START trial

START trial provides definitive evidence of the benefits of early HIV treatment.


Treatment as prevention

No HIV infections from partners with suppressed viral load during follow up of treatment as prevention trial.

Harm reduction

Opioid substitution therapy combined with HIV treatment saves the lives of more drug users than ART alone.

HIV testing guidelines

WHO urges more HIV testing by non-medical staff, outside of clinical settings.


Access to hepatitis care

Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection.

Treatment guidelines

World Health Organization to recommend HIV treatment for all.

Towards an HIV cure

Targets proliferate in HIV cure research.


aidsmap news

There is no aidsmap news from IAS 2015 yet. Showing all aidsmap news instead.

Editors' picks from other sources

There are no Editors' Picks from IAS 2015 yet. Showing all Editors' picks instead.

Email bulletins

Sign up for our news bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference and view the programme on the official conference website.

Visit the official IAS website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news apps for android and iPhone.

Download the app >

NAM's coverage of the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) has been made possible thanks to support from Bristol-Myers Squibb, Gilead, Merck & Co., Inc., and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.